We use cookies and other data for a number of reasons, such as keeping FT Sites reliable and secure, personalising content and ads, providing social media features and to analyse how our Sites are used.
Add this topic to your myFT Digest for news straight to your inbox
Science secretary Michelle Donelan signs post-Brexit deal to rejoin €96bn research scheme
Use of technology to solve scientific problems still falls short of commercialisation
‘Treasure trove’ will be used to develop drugs and treatments for wide range of diseases and is culmination of 20 years of work
Government to boost spending on computing power by £500mn to develop artificial intelligence
Google DeepMind’s model beat world’s leading system in 90% of metrics used and took only a fraction of the time
Scientists hope rocks and dust taken from 4.7bn-year-old Bennu will provide clues to formation of solar system
Scientists and business welcome plan for Britain to go back into multilateral project
When it comes to academic papers, the line between fraud and substandard science can sometimes seem a little… academic
New model aims to reduce high development costs and increase number of drugs being tested
Joint work would avoid ‘deep scars’ caused by unequal access to drugs during Covid-19
‘Another Brick in the Wall’ study could help people with severe neurological damage to communicate
New research challenges idea that people have continuously lived in region since first arriving
If it wants to be an innovation superpower, the UK needs to rejoin €95bn EU programme
Move to terminate scientific project comes as Facebook parent prioritises moneymaking AI products over blue-sky research
Incipient industry will need decades, and many billions, before it becomes a commercial proposition
Scandals at Stanford and Harvard show manipulation of research remains an issue despite growth of ‘data detectives’
UK indecision about its place in the EU research programme is already damaging universities
British ministers are hoping to finalise agreement on participation in science research scheme this month
Leading figures frustrated over ‘absurd’ delays to Britain rejoining research programme
Scientists apply deep learning to expanded DNA database to help identify disease-causing mutations in humans
Human life appears to have an upper limit that has yet to be extended
Alzheimer’s advocates call for ambitious declaration to match the scope of commitments made 10 years ago
Britain complains it is expected to pay too much to rejoin flagship research project
One in 5 biomedical articles may contain faked data, with Chinese paper mills leading way
Hurdles facing drug trials point to challenges for Britain’s drive for innovation
International Edition
